Clinical trial NEORHEA
Neoadjuvant Biomarker ResearcH Study of Palbociclib Combined with Endocrine Therapy in Estrogen Receptor Positive/ HER2 Negative Breast CAncer
| Cancers | |
|---|---|
| Organ | Breast |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Oui |
| Sponsor | Institut Jules Bordet |
| EudraCT Identifier | 2016-000879-24 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03065621 |
| Inclusion criteria | ER+/HER2-. Neoadjuvant. Palbociclib |
| Last update |